LPTs inhibited infections with wild type HIV-1 and VSV-pseudotyped HIV-1 which enters T cells independently of CD4 and co-receptors, with similar IC50 values suggesting a non-entry target for all the LPTs and, of course, for bevirimat (Figure 2). This evidence concerns the gene CD4 and infection.